| Item Type | Name |
|
Concept
|
AC133 Antigen
|
|
Concept
|
Celecoxib
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Animals
|
|
Concept
|
Anti-Inflammatory Agents
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Antigens, Polyomavirus Transforming
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Eflornithine
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Carcinogens
|
|
Concept
|
Carcinoma in Situ
|
|
Concept
|
Urinary Bladder Neoplasms
|
|
Concept
|
Adenoma
|
|
Concept
|
Carcinoma, Transitional Cell
|
|
Concept
|
Catechin
|
|
Concept
|
Cell Movement
|
|
Concept
|
Chromans
|
|
Concept
|
Colonic Neoplasms
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Cyclic GMP
|
|
Concept
|
Hormones
|
|
Concept
|
Humans
|
|
Concept
|
Genotype
|
|
Concept
|
Lipoxygenase
|
|
Concept
|
Glutamine
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Inflammation
|
|
Concept
|
Nicotine
|
|
Concept
|
Mutation
|
|
Concept
|
Naproxen
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Neovascularization, Pathologic
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Phenylurea Compounds
|
|
Concept
|
Phosphoric Diester Hydrolases
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Tobacco
|
|
Concept
|
Pyrimidines
|
|
Concept
|
Pyrroles
|
|
Concept
|
Technetium
|
|
Concept
|
Transfection
|
|
Concept
|
Rats, Inbred F344
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
Meta-Analysis as Topic
|
|
Concept
|
Stilbenes
|
|
Concept
|
Rats, Wistar
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Lipoxygenase Inhibitors
|
|
Concept
|
Proliferating Cell Nuclear Antigen
|
|
Concept
|
Mucin-1
|
|
Concept
|
CD13 Antigens
|
|
Concept
|
Disease Progression
|
|
Concept
|
Chemoprevention
|
|
Concept
|
Micronutrients
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Drug Delivery Systems
|
|
Concept
|
Sirolimus
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Anticarcinogenic Agents
|
|
Concept
|
Arachidonic Acid
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Receptors, G-Protein-Coupled
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Receptor, Cholecystokinin B
|
|
Concept
|
Adenomatous Polyposis Coli Protein
|
|
Concept
|
bcl-X Protein
|
|
Concept
|
bcl-2-Associated X Protein
|
|
Concept
|
Mice
|
|
Concept
|
Rats
|
|
Concept
|
Observational Studies as Topic
|
|
Concept
|
Ornithine Decarboxylase Inhibitors
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Tomography, Emission-Computed, Single-Photon
|
|
Concept
|
Gene Expression Regulation, Neoplastic
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Polyphenols
|
|
Concept
|
Uroplakin II
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
ErbB Receptors
|
|
Concept
|
Lignans
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Ribosomal Protein S6 Kinases, 90-kDa
|
|
Concept
|
Isothiocyanates
|
|
Concept
|
Alendronate
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Carcinoma, Pancreatic Ductal
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Fatty Acid Synthases
|
|
Concept
|
Emulsifying Agents
|
|
Concept
|
Tissue Array Analysis
|
|
Concept
|
Cyclooxygenase 2 Inhibitors
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
Receptors, Enterotoxin
|
|
Concept
|
Arachidonate 5-Lipoxygenase
|
|
Concept
|
Arginine
|
|
Concept
|
Aspirin
|
|
Concept
|
Cell Transformation, Neoplastic
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Disease Susceptibility
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Food, Formulated
|
|
Concept
|
Immunoenzyme Techniques
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Metformin
|
|
Concept
|
Ornithine Decarboxylase
|
|
Academic Article
|
Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression.
|
|
Academic Article
|
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model.
|
|
Academic Article
|
Anti-inflammatory phytochemicals for chemoprevention of colon cancer.
|
|
Academic Article
|
Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
|
|
Academic Article
|
Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases.
|
|
Academic Article
|
Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression.
|
|
Academic Article
|
Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
|
|
Academic Article
|
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma.
|
|
Academic Article
|
Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice.
|
|
Academic Article
|
Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention.
|
|
Academic Article
|
Cancer stem cell markers as potential targets for epithelial cancers.
|
|
Academic Article
|
Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
|
|
Academic Article
|
Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives.
|
|
Academic Article
|
p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.
|
|
Academic Article
|
TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma.
|
|
Academic Article
|
Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer.
|
|
Academic Article
|
Development of a dietary formulation of the SHetA2 chemoprevention drug for mice.
|
|
Academic Article
|
Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.
|
|
Academic Article
|
Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma.
|
|
Academic Article
|
Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice.
|
|
Academic Article
|
Targeting triglyceride metabolism for colorectal cancer prevention and therapy.
|
|
Academic Article
|
Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat.
|
|
Academic Article
|
Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism.
|